mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |